BioE Receives FDA 510(k) Clearance For Cord Blood Processing System (Medical News Today)
BioE , Inc., a biomedical company that provides enabling cord blood stem cell tools and technologies, announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PrepaCyte -CB Processing System for umbilical cord blood.

FDA Approves Fibromyalgia Drug - Savella(TM) (milnacipran HCl), A Selective Serotonin And Norepinephrine Dual Reuptake ... (Medical News Today)
Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella(TM) (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia.